Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy
Angewandte Chemie International Edition · 09.11.2026 · 65 (46)
DOI: 10.1002/anie.5354099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 27.08.2026. Verfasst von Shu Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Organelles, Membrane Proteins. Die Arbeit nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Research Grants Council, National Natural Science Foundation of China, Science Technology and Innovation Committee of Shenzhen Municipality.
Abstract (Originalsprache)
Photodynamic therapy (PDT) and photoactivated chemotherapy (PACT) have emerged as promising anticancer modalities due to their noninvasive nature, spatiotemporal precision, and high tumor suppression efficacy. Integrating platinum with these phototherapies addresses key limitations of conventional platinum chemotherapy, specifically systemic toxicity and pervasive drug resistance. Since cancer cell membrane proteins, including receptors and transporters, and subcellular organelles play a pivotal role as therapeutic targets, directing platinum phototherapeutics to membrane proteins or specific organelles markedly enhances efficacy compared to nonspecific targeting. Consequently, membrane protein‐ and organelle‐targeted platinum‐based phototherapeutics represent a transformative advance in cancer treatment. This review highlights recent advancements in membrane protein‐/organelle‐targeted and photoactivated platinum complexes and explains how targeting improves efficacy, reduces resistance, and has the potential to minimize off‐target toxicity. We examine the therapeutic benefits derived from localized generation of reactive oxygen species, light‐triggered release of cytotoxic species, and activation of organelle‐specific cell death pathways. These insights may guide the rational design of next‐generation photoactivatable platinum complexes, offering opportunities for improved therapeutic outcomes through synergistic mechanisms and precise targeting strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China.
- City University of Hong Kong Shenzhen Research Institute, Shenzhen, China.
ORCID-Profile: Shu Chen, Guangyu Zhu
Förderung
- Hong Kong Research Grants Council
- National Natural Science Foundation of China
- Science Technology and Innovation Committee of Shenzhen Municipality
- City University of Hong Kong
Zitieren
APA
Chen, S., Zhou, Q., Xu, J., & Zhu, G. (2026). Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy. Angewandte Chemie International Edition, 65(46). https://doi.org/10.1002/anie.5354099
Vancouver
Chen S, Zhou Q, Xu J, Zhu G. Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy. Angewandte Chemie International Edition. 2026;65(46). doi:10.1002/anie.5354099
BibTeX
@article{Chen2026,
author = {Chen, Shu and Zhou, Qiyuan and Xu, Jiaqian and Zhu, Guangyu},
title = {Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {46},
doi = {10.1002/anie.5354099}
}
EUVIMED